Efficacy of cryotherapy in the prevention of chemotherapy-related oral mucositis
DOI:
https://doi.org/10.35381/s.v.v8i1.3912Keywords:
Cryotherapy, complementary therapies, climatotherapy, (Source: DeCS)Abstract
Objective: To analyze the efficacy of cryotherapy as a method for the prevention of oral mucositis in chemotherapy patients. Method: Descriptive documentary. Conclusion: The evidence for the efficacy of oral cryotherapy in the prevention of oral mucositis is mixed and further research is needed to draw firm conclusions. Each patient should consult with their medical team to assess the potential benefits and risks of oral cryotherapy in their particular situation.
Downloads
References
Scardina GA, Pisano T, Messina P. Oral mucositis. Review of literature. N Y State Dent J. 2010;76(1):34-38.
Vokurka S, Chvojkova I, Svoboda T, et al. The impact of oral cryotherapy and oral and gastrointestinal mucositis after autologous stem cell transplantation. Eur J Oncol Nurs. 2014;18(2):228-229. https://doi.org/10.1016/j.ejon.2013.11.001
Al-Rudayni AHM, Gopinath D, Maharajan MK, Veettil SK, Menon RK. Efficacy of Oral Cryotherapy in the Prevention of Oral Mucositis Associated with Cancer Chemotherapy: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Curr Oncol. 2021;28(4):2852-2867. https://doi.org/10.3390/curroncol28040250
Riley P, Glenny AM, Worthington HV, et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Database Syst Rev. 2017;11(11):CD011990. https://doi.org/10.1002/14651858.CD011990.pub2
Spivakovsky S. Oral cryotherapy reduced oral mucositis in patients having cancer treatments. Evid Based Dent. 2016;17(3):80. https://doi.org/10.1038/sj.ebd.6401186
Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG. Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database Syst Rev. 2015;2015(12):CD011552. https://doi.org/10.1002/14651858.CD011552.pub2
Bhatt V, Vendrell N, Nau K, Crumb D, Roy V. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation. J Oncol Pharm Pract. 2010;16(3):195-204. https://doi.org/10.1177/1078155209348721
Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST. The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin. 2022;72(1):57-77. https://doi.org/10.3322/caac.21704
Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Cancer-Related Fatigue: Causes and Current Treatment Options. Curr Treat Options Oncol. 2020;21(2):17. https://doi.org/10.1007/s11864-020-0707-5
Cronshaw M, Parker S, Anagnostaki E, Mylona V, Lynch E, Grootveld M. Photobiomodulation and Oral Mucositis: A Systematic Review. Dent J (Basel). 2020;8(3):87. https://doi.org/10.3390/dj8030087
Colella G, Boschetti CE, Vitagliano R, et al. Interventions for the Prevention of Oral Mucositis in Patients Receiving Cancer Treatment: Evidence from Randomized Controlled Trials. Curr Oncol. 2023;30(1):967-980. https://doi.org/10.3390/curroncol30010074
Sonis ST. Oral mucositis in head and neck cancer: risk, biology, and management. Am Soc Clin Oncol Educ Book. 2013;10.1200/EdBook_AM.2013.33.e236.
Bolton L. Managing Oral Mucositis in Patients with Cancer. Wounds. 2021;33(5):136-138.
Xia C, Jiang C, Li W, et al. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma. Front Immunol. 2021;12:618150. https://doi.org/10.3389/fimmu.2021.618150
Walinski CJ, Mellusi SM, Brodeur AE, Marchick E, Katz D, Van Putten M. Review of oral mucositis treatment guidelines with an emphasis on laser therapy. Gen Dent. 2022;70(2):22-26.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ana Paulina Oñate-Silva, Dayanna Elizabeth Pàstor-Sanmartin, Viviana Marcela Hidalgo-Moya
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
